Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabeth Wik

Showing results (21-30 of 70) with videos related to

Pageof 7
Sort By:
Plos One|February 16, 2017
Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancerSura Aziz, Elisabeth Wik, Gøril Knutsvik, et al.
Plos One|March 9, 2016
Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast CancerSura Aziz, Elisabeth Wik, Gøril Knutsvik, et al.
Frontiers in Medicine|June 24, 2025
Predicting estrogen receptor status from HE-stained breast cancer slides using artificial intelligenceMaren Høibø, Ute Spiske, André Pedersen, et al.
Breast Cancer Research and Treatment|May 24, 2023
Vessel size as a marker of survival in estrogen receptor positive breast cancerVladan Milosevic, Reidunn J Edelmann, Ingeborg Winge, et al.
Diagnostic Pathology|December 20, 2014
Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based studyYing Chen, Tor A Klingen, Elisabeth Wik, et al.
Scientific Reports|February 10, 2021
Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancerKristi Krüger, Laxmi Silwal-Pandit, Elisabeth Wik, et al.
Scientific Reports|February 15, 2025
Distinct clinicopathological features and treatment differences in breast cancer patients of young ageRasmus O C Humlevik, Amalie A Svanøe, Turid Aas, et al.
Histopathology|October 20, 2010
Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancerJone Trovik, Elisabeth Wik, Ingunn Stefansson, et al.
NPJ Breast Cancer|April 9, 2026
Stromal-based proteome data improve stratification of hormone receptor-positive breast cancerKenneth Finne, Silje Kjølle, Magdalena Ríos Romero, et al.
Plos One|August 1, 2017
C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive diseaseJohannes Landskron, Sigrid M Kraggerud, Elisabeth Wik, et al.
Pageof 7

Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Plos One|February 16, 2017
Extra-nodal extension is a significant prognostic factor in lymph node positive breast cancerSura Aziz, Elisabeth Wik, Gøril Knutsvik, et al.
Plos One|March 9, 2016
Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast CancerSura Aziz, Elisabeth Wik, Gøril Knutsvik, et al.
Frontiers in Medicine|June 24, 2025
Predicting estrogen receptor status from HE-stained breast cancer slides using artificial intelligenceMaren Høibø, Ute Spiske, André Pedersen, et al.
Breast Cancer Research and Treatment|May 24, 2023
Vessel size as a marker of survival in estrogen receptor positive breast cancerVladan Milosevic, Reidunn J Edelmann, Ingeborg Winge, et al.
Diagnostic Pathology|December 20, 2014
Breast cancer stromal elastosis is associated with mammography screening detection, low Ki67 expression and favourable prognosis in a population-based studyYing Chen, Tor A Klingen, Elisabeth Wik, et al.
Scientific Reports|February 10, 2021
Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancerKristi Krüger, Laxmi Silwal-Pandit, Elisabeth Wik, et al.
Scientific Reports|February 15, 2025
Distinct clinicopathological features and treatment differences in breast cancer patients of young ageRasmus O C Humlevik, Amalie A Svanøe, Turid Aas, et al.
Histopathology|October 20, 2010
Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancerJone Trovik, Elisabeth Wik, Ingunn Stefansson, et al.
NPJ Breast Cancer|April 9, 2026
Stromal-based proteome data improve stratification of hormone receptor-positive breast cancerKenneth Finne, Silje Kjølle, Magdalena Ríos Romero, et al.
Plos One|August 1, 2017
C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive diseaseJohannes Landskron, Sigrid M Kraggerud, Elisabeth Wik, et al.
Pageof 7